News Digital health firm Biofourmis adds another $20m to its fund... One of the digital health sector's latest unicorn companies – Biofourmis – has upscaled its recent fourth round financing, adding $20 million to the $300 million it
Views & Analysis Digital health round-up: Is AR the new VR? A round-up of this week’s digital healthcare news. Marco Ricci reports.
News Teva collaborates with Intel to develop Huntington's smartwa... Teva enters the machine learning market.
News Dupixent is first FDA-approved drug for rare skin disease The long list of therapeutic uses for Sanofi and Regeneron's Dupixent has been lengthened by an FDA approval for rare skin disease bullous pemphigoid.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face